Health Products

Glucovision (Citrate) (2020-05-11)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Radiopharmaceuticals
Issue: Product Safety
Audience: Healthcare Professionals, Hospitals, General Public
Department: Health Canada
Hazard classification: Type III

Summary

Product

Glucovision (Citrate) 453 GBq/vial

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
T-200511FDG-1
Recalling Firm
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA
Marketing Authorization Holder
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA
Glucovision (Citrate) 453 GBq/vialDIN 02328771SolutionFludeoxyglucose 18F 453 GBq/vial

Reason

Affected lot contains ethanol levels outside of the labelled claim.

Depth of distribution

Healthcare establishments
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime